RECOVER™
3.6.2022 07:02:06 CEST | Business Wire | Press release
Recover™, a leading materials science company and recycled cotton fiber producer, reaffirmed its commitment to the Sustainable Development Goals (SDGs) as it actively participated in the United Nations Conscious Fashion and Lifestyle Network Annual Meeting yesterday, held at the United Nations Headquarters, New York.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005659/en/
Considering the significant impact of the fashion sector on societies and the environment, the meeting joined together key industry stakeholders, media, Governments, and United Nations system entities to showcase and enable collaborations that accelerate the implementation of the SDGs in the industry.
In an exclusive fireside chat, Alfredo Ferre, CEO at Recover™, highlighted the importance of recycled cotton in achieving these goals, and in scaling its production to accelerate the transition to a more sustainable fashion industry. As a global producer of recycled cotton fiber and cotton fiber blends, Recover™ is an important actor within the supply chain to drive change and the company aims to be the first in its space to scale its high-value technology globally.
The company has already shown its commitment to taking actions that benefit the wider community and allow the scaling of the traceable and resilient circular supply chains needed to achieve climate targets. It recently formalized its membership to the largest initiative in Social Responsibility in the world, the United Nations Global Compact, and its strategy is strongly aligned with the United Nations 2030 Agenda and the achievement of the 17 SDGs. The company has registered its commitments to sector change on the United Nations Conscious Fashion and Lifestyle Network.
Alfredo Ferre stated: “Throughout our 75-year history, the 17 Sustainable Development Goals have been ingrained into our DNA and strategy at Recover™, and we are proud to support the United Nations Conscious Fashion and Lifestyle Network Annual Meeting to help engage the fashion industry to accelerate action in achieving them. By collaborating with these global stakeholders, we hope to scale our impact further to help brands and retailers meet their sustainable goals.”
Kerry Bannigan, Co-Founder, UN Conscious Fashion and Lifestyle Network and Executive Director, Fashion Impact Fund added: “Thank you to Recover™ for supporting and joining our convening to showcase solutions for sector wide change and champion how our network commitments are mobilizing expertise, innovation, technology, and resources towards a responsible and inclusive COVID-19 recovery, with the Sustainable Development Goals as a guiding framework.”
The United Nations Conscious Fashion Campaign and Lifestyle Network is a joint initiative of the United Nations Office for Partnerships, the Division for Sustainable Development Goals - United Nations Department of Economic and Social Affairs, and the Fashion Impact Fund. The online platform supports solutions for sustainable innovation, and this meeting is one of the key periodic events held by the platform, aimed at driving innovation, connecting industry leaders, facilitating new partnerships, and enacting social change.
About Recover™
Recover™ is a leading materials science company and global producer of low-impact, high-quality recycled cotton fiber and cotton fiber blends. Its premium, environmentally friendly, and cost-competitive products are created in partnership with the supply chain for global retailers and brands, offering a sustainable solution to achieve circular fashion for all. As a fourth-generation, family-owned company with over a 70-year history in the textile industry, Recover™ is on a mission to scale its proprietary technology to make a lasting positive impact on the environment and partner with brands/retailers and other change-makers to meet the industry’s sustainability targets.
For more information, visit www.recoverfiber.com and follow @recoverfiber on social media.
About Conscious Fashion and Lifestyle Network
The Conscious Fashion and Lifestyle Network is a United Nations (UN) hosted online platform for industry stakeholders, media, Governments, and UN system entities. The network showcases and enables collaborations that accelerate the implementation of the Sustainable Development Goals. The UN Conscious Fashion and Lifestyle Network is a joint initiative of the United Nations Office for Partnerships, the Division for Sustainable Development Goals - United Nations Department of Economic and Social Affairs, and the Fashion Impact Fund. The leading entities of the network convene periodic events aligned with key meetings on the UN calendar and publish reports on the network’s achievements.
https://sdgs.un.org/partnerships/action-networks/conscious-fashion-and-lifestyle-network
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005659/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom